12.19
Mobia Medical Inc stock is traded at $12.19, with a volume of 130.86K.
It is down -7.37% in the last 24 hours and down -4.17% over the past month.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.
See More
Previous Close:
$13.16
Open:
$13.24
24h Volume:
130.86K
Relative Volume:
1.18
Market Cap:
$405.31M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.70%
1M Performance:
-4.17%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Mobia Medical Inc Stock (MOBI) Company Profile
Name
Mobia Medical Inc
Sector
Industry
Phone
(855) 628-9375
Address
2802 FLINTROCK TRACE, SUITE 226, AUSTIN
Compare MOBI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MOBI
Mobia Medical Inc
|
12.19 | 405.31M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Mobia Medical Inc Stock (MOBI) Latest News
Micro Ti Investment, Llc Net Worth (2026) - GuruFocus
Gpg Healthcare Opportunities Fund Ii, Llc Net Worth (2026) - GuruFocus
Micro Ti Investment 2, Llc Net Worth (2026) - GuruFocus
Gpg Phl, Llc Net Worth (2026) - GuruFocus
Mti 20 Investment, Llc Net Worth (2026) - GuruFocus
Price to earnings forward of Mobia Medical, Inc. – NASDAQ:MOBI - TradingView
Mobia Medical (MOBI) Revenue BreakdownMain Composition - Moomoo
MOBI SEC FilingsMobia Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Mobia Medical prices IPO at $15 per share, targets $150m - Investing.com
CMS proposes to maintain Vivistim procedure payment rate at $45,000 - Investing.com
CMS proposes to maintain Vivistim procedure payment rate at $45,000 By Investing.com - Investing.com India
Mobia Medical Announces Vivistim® Procedure Remains - GlobeNewswire
Mobia Medical Announces Vivistim Procedure Remains Assigned to New Technology APC 1580 Under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule - Moomoo
Mobia Medical (MOBI) insiders convert preferred, notes and add 33K common shares - Stock Titan
Green Park & Golf Ventures lists pre-IPO Mobia Medical (MOBI) holdings - Stock Titan
BTIG Maintains Mobia Medical(MOBI.US) With Buy Rating, Maintains Target Price $19 - Moomoo
Vivistim by Mobia Medical - ABC27
Mobia Medical, Inc.(NasdaqGS: MOBI) added to S&P TMI Index - marketscreener.com
Mobia Medical (MOBI) Registration filing Summary - Quartr
Prashant B. Rawat Net Worth (2026) - GuruFocus
Osage University Gp Iv, Llc Net Worth (2026) - GuruFocus
Osage University Partners Iv, Lp Net Worth (2026) - GuruFocus
Mobia COO exercises options for 15,000 shares | MOBI Insider Trading - Stock Titan
Mobia Medical (MOBI) CFO adds 5,000 shares in open-market buy and updates pre-IPO distributions - Stock Titan
Douglas T Ellison Net Worth (2026) - GuruFocus
MOBI Technical Analysis & ETF Price Forecast - Intellectia AI
MOBI: VivistimⓇ therapy drives transformative stroke recovery, fueling rapid growth and market expansion - TradingView
This Oppenheimer analyst begins coverage on a bullish note; here are top 5 initiations for Tuesday - MSN
MOBI: Q1 2026 revenue grew 113% to $12.1M, but net loss widened to $17.7M amid rapid expansion - TradingView
Mobia Medical (MOBI) doubles Q1 revenue but posts $17.7M net loss - Stock Titan
Bank of America Initiates Mobia Medical Stock with Buy Rating - sekbernews.id
Mobia Medical poised for commercial expansion, BofA says in initial coverage - Yahoo! Finance Canada
BofA Securities Initiates Mobia Medical(MOBI.US) With Buy Rating, Announces Target Price $16 - Moomoo
BTIG Initiates Mobia Medical(MOBI.US) With Buy Rating, Announces Target Price $19 - Moomoo
Mobia Medical Price Target Announced at $16.00/Share by B of A Securities - Moomoo
MOBI Initiated by JP Morgan -- Price Target Set at $15.00 - GuruFocus
MOBI Initiated Coverage by BTIG -- Price Target Set at $19.00 - GuruFocus
MOBI Initiated by Goldman Sachs -- Price Target Announced at $31 - GuruFocus
This Oppenheimer Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Mobia Medical Initiated at Buy by B of A Securities - Moomoo
Mobia Medical gains Goldman Sachs buy rating as bank sees 130% upside - Traders Union
MOBI | Mobia Medical, Inc. Common Stock Data, Price & News - Quiver Quantitative
MOBI | Mobia Medical, Inc. Common Institutional Ownership - Quiver Quantitative
MOBI | Mobia Medical, Inc. Common Analyst Forecasts - Quiver Quantitative
J.P. Morgan Initiates Mobia Medical(MOBI.US) With Buy Rating, Announces Target Price $15 - Moomoo
Wolfe Research initiates Mobia Medical stock with outperform rating By Investing.com - Investing.com Canada
Goldman Sachs Initiates Mobia Medical at Buy With $31 Price Target - Moomoo
JPMorgan initiates Mobia Medical stock with Overweight rating By Investing.com - Investing.com Australia
Goldman Sachs initiates Mobia Medical stock with buy rating on neuro tech - Investing.com
JPMorgan initiates Mobia Medical stock with Overweight rating - Investing.com
Mobia Medical Drops Back Under IPO as Investors Question Stroke Device Plan - Bez Kabli
Mobia Medical Inc Stock (MOBI) Financials Data
There is no financial data for Mobia Medical Inc (MOBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):